Assistant Professor, Department of Pharmacy; Affiliate Investigator, Cancer Prevention Program, Fred Hutchinson Cancer Research Center
PhD in Public Health Genetics, University of Washington; Master of Public Health in Public Health Genetics, University of Washington; Bachelor of Arts in Environmental, Population, and Organismic Biology, University of Colorado, Boulder
- Comparative effectiveness research
- Value of information analysis in health technology evaluation
- Biomarker development and implementation
- PHARM 520: Introduction to Pharmacoeconomics and Outcomes Research
- MEDCH 535: Pharmacogenomics Lecture
- HECON 520. Economic Evaluation in Healthcare
- PHARM 534: Economic Evaluation in Health & Medicine
Dr. Josh Carlson graduated with his PhD from the Institute for Public Health Genetics in the School of Public Health and Community Medicine at the University of Washington in 2007 and received his Master of Public Health from the same department in 2004. Carlson is an assistant professor in the Pharmaceutical Outcomes Research and Policy Program and an affiliate faculty member at the Fred Hutchinson Cancer Research Center. Dr. Carlson conducted his postdoctoral training in pharmacoeconomics with the University of Washington from 2007-2009.
Dr. Carlson's current research interests and work to date has primarily focused on the intersection of three areas: 1) genomics and emerging technologies in the field of personalized medicine, 2) uncertainty both in our decision-making processes and as the concept applies to the application of medical technologies in "real world" settings (i.e. outside of clinical trials) including comparative effectiveness research, and 3) economic and policy options to address these uncertainties as we seek to improve our healthcare system and the health of our population.